Rifaximin for the treatment of hepatic encephalopathy

Transplantation Proceedings

Volumn 42, Issue 10, 2010, Pages 4543-4547

  Mantry, P S ^a   Munsaf, S ^b  

^a METHODIST DALLAS MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTULOSE; RIFAXIMIN;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADD ON THERAPY; ADULT; AGED; BACTERIAL PERITONITIS; BLOATING; CLINICAL EVALUATION; CONFERENCE PAPER; DEHYDRATION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK; SPONTANEOUS BACTERIAL PERITONITIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RIFAMYCINS;

EID: 78649638066     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.173     Document Type: Conference Paper

References (23)

1. G. Garcia-Tsao Portal hypertension Curr Opin Gastroenterol 21 2005 313
2. P. Gins, A. Crdenas, and V. Arroyo Management of cirrhosis and ascites N Engl J Med 350 2004 1646
3. A.T. Blei, J. Crdoba and the Practice Parameters Committee of the American College of Gastroenterology Hepatic encephalopathy Am J Gastroenterol 96 2001 1968
4. D. Festi, A. Vestito, and G. Mazzella Management of hepatic encephalopathy: focus on antibiotic therapy Digestion 73 suppl 1 2006 94
5. K.R. Lawrence, and J.A. Klee Rifaximin for the treatment of hepatic encephalopathy Pharmacotherapy 28 2008 1019
6. R. Williams, and N. Bass Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety Rev Gastroenterol Disord 5 suppl 1 2005 S10
7. D. Hussinger, and F. Schliess Pathogenetic mechanisms of hepatic encephalopathy Gut 57 2008 1156
8. K.D. Mullen, P. Ferenci, and N.M. Bass An algorithm for the management of hepatic encephalopathy Semin Liver Dis 27 suppl 2 2007 32
9. C.A. Stewart, M. Malinchoc, and W.R. Kim Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease Liver Transpl 13 2007 1366
10. W.C. Maddrey Role of antibiotics in the management of hepatic encephalopathy Rev Gastroenterol Disord 5 suppl 1 2005 S3
11. H.L. Koo, and H.L. DuPont Current and future developments in travelers' diarrhea therapy Expert Rev Anti Infect Ther 4 2006 417
12. Z.D. Jiang, and H.L. DuPont Rifaximin: in vitro and in vivo antibacterial activitya review Chemotherapy 51 suppl 1 2005 67
13. C.B. Leevy, and J.A. Phillips Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy Dig Dis Sci 52 2007 737
14. G.W. Neff, N. Kemmer, and V.C. Zacharias Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy Transplant Proc 38 2006 3552
15. J.A. Talwalkar, and P.S. Kamath Influence of recent advances in medical management on clinical outcomes of cirrhosis Mayo Clin Proc 80 2005 1501
16. R. Cheruvattath, and V. Balan Infections in patients with end-stage liver disease J Clin Gastroenterol 41 2007 403
17. J. Reichen, and D. Lebrec The future treatment of portal hypertension Best Pract Res Clin Gastroenterol 21 2007 191
18. C. Scarpignato, and I. Pelosini Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential Chemotherapy 51 suppl 1 2005 36
19. C.B. Leevy Economic impact of treatment options for hepatic encephalopathy Semin Liver Dis 27 suppl 2 2007 26
20. L. Bucci, and G.C. Palmieri Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy Curr Med Res Opin 13 1993 109
21. F. Giacomo, A. Francesco, and N. Michele Rifaximin in the treatment of hepatic encephalopathy Eur J Clin Res 4 1993 57
22. P. Massa, E. Vallerino, and M. Dodero Treatment of hepatic encephalopathy with rifaximin:double-blind, double-dummy study versus lactulose Eur J Clin Res 4 1993 7
23. N.M. Bass, K.D. Mullen, and A. Sanyal Rifaximin treatment in hepatic encephalopathy N Engl J Med 362 2010 1071